Arca
Skip to content

Allogran-R

Filler, Bone Void, Calcium Compound. 510(k) K061311, from Biocomposites, Ltd. (Keele, GB). Product code MQV, class 2.

As of Nov 17, 2026, K061311 is an FDA 510(k) held by Biocomposites, Ltd., substantially equivalent on Sep 22, 2006 after 135 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Sep 22, 2006
  • Review time: 135 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

Allogran-R® is a resorbable implant intended to fill bony voids or gaps that are not intrinsic to the stability of the bony structure (e.g., the extremities, spine or pelvis) and may be combined with saline or blood. Defects may be due to trauma or surgery.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other MQV Clearances

The newest 510(k)s for the same product code; their median review was 96 days; see every MQV device

Record

Type
Traditional
Received
May 10, 2006
Review panel
Orthopedic
Regulation
21 CFR 888.3045

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.